Zhou Lu-Qian, Li Xiao-Ying, Li Yun, Guo Bing-Peng, Guan Li-Li, Chen Xin, Luo Yu-Wen, Luo Peng, Chen Rong-Chang
Frist Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China. E-mail:
Nan Fang Yi Ke Da Xue Xue Bao. 2016 Aug 20;36(8):1069-74.
To investigate the effects of inspiratory muscle training followed by non-invasive positive pressure ventilation in patients with severe chronic obstructive pulmonary disease (COPD).
This investigator-initiated randomized, controlled trial recruited 88 patients with stable GOLD stage IV COPD, who were randomized into 4 equal groups to continue oxygen therapy (control group) or to receive inspiratory muscle training followed by non-invasive positive pressure ventilation (IMT-NPPV group), inspiratory muscle training only (IMT group), or noninvasive positive pressure ventilation only (NPPV group) for at least 8 weeks. The outcomes of the patients were assessed including the quality of life (SRI scores), maximum inspiratory pressure (MIP), maximum expiratory pressure (MEP), dyspnea (MRC scores), 6-min walking distance (6MWD) and lung function.
s Compared to baseline values, SRI scores, 6MWT and MRC scores increased significantly after 8 weeks in IMT-NPPV, IMT and NPPV groups, and the improvements were significantly greater in IMT-NPPV group than in IMT and NPPV groups (P<0.05 for all). In IMT-NPPV and IMT groups, MIP and MEP increased significantly after the training (P<0.05), and the improvement was more prominent in IMT-NPPV group (P<0.05). No significant changes were found in pulmonary functions in the groups after 8 weeks of treatment (P>0.05).
Inspiratory muscle training followed by non-invasive positive pressure ventilation, compared with inspiratory muscle training or non-invasive positive pressure ventilation alone, can better enhance the quality of life, strengthen the respiratory muscles, improve exercise tolerance and relieve the dyspnea in patients with COPD.
探讨吸气肌训练联合无创正压通气对重度慢性阻塞性肺疾病(COPD)患者的影响。
本研究者发起的随机对照试验纳入了88例稳定期GOLD Ⅳ级COPD患者,将其随机分为4组,分别为继续吸氧治疗(对照组)或接受吸气肌训练联合无创正压通气(IMT-NPPV组)、仅接受吸气肌训练(IMT组)或仅接受无创正压通气(NPPV组),治疗至少8周。评估患者的生活质量(SRI评分)、最大吸气压(MIP)、最大呼气压(MEP)、呼吸困难(MRC评分)、6分钟步行距离(6MWD)和肺功能等结局指标。
与基线值相比,IMT-NPPV组、IMT组和NPPV组在8周后SRI评分、6MWT和MRC评分均显著升高,且IMT-NPPV组的改善程度显著大于IMT组和NPPV组(均P<0.05)。在IMT-NPPV组和IMT组中,训练后MIP和MEP显著升高(P<0.05),且IMT-NPPV组的改善更显著(P<0.05)。治疗8周后,各组肺功能无显著变化(P>0.05)。
与单独进行吸气肌训练或无创正压通气相比,吸气肌训练联合无创正压通气能更好地提高COPD患者的生活质量、增强呼吸肌力量、改善运动耐力并缓解呼吸困难。